The medical community's appetite for high-resolution, multi-parametric data has reached an all-time high, fundamentally altering Spectral Computed Tomography Market Demands. In 2026, the primary demand driver is the urgent need for earlier and more accurate oncology staging. Conventional CT often struggles with "indeterminant" lesions, which lead to patient anxiety and expensive biopsies....